APLIF
Price:
$0.015
Market Cap:
$3.03M
Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in the infectious disease in Canada. Its anti-infective portfolio includes Favipiravir for pandemic influenza and COVID-19; ATI-2307, an antifungal candidate, which is in clinical stage for the treatment of cryptococcal meningitis and invasive candidiasis; ATI-1503 that develops a class of gram-negative targeting antibiotics; ATI-1501, a taste-masked liquid oral suspension formulation of an antibiotic, metronidazole; ATI-1801, a novel topical formulation of paromomycin for the treatment of cutaneous leishmaniasis; and ATI-1701 is a live-attenuated vaccine for F...[Read more]
Industry
Biotechnology
IPO Date
2021-01-08
Stock Exchange
OTC
Ticker
APLIF
According to Appili Therapeutics Inc.’s latest financial reports and current stock price. The company's current ROE is 16.72%. This represents a change of 308.90% compared to the average of 4.09% of the last 4 quarters.
The mean historical ROE of Appili Therapeutics Inc. over the last ten years is 51.81%. The current 16.72% ROE has changed -67.73% with respect to the historical average. Over the past ten years (40 quarters), APLIF's ROE was at its highest in in the December 2021 quarter at 746.09%. The ROE was at its lowest in in the December 2019 quarter at -161.59%.
Average
51.81%
Median
-61.23%
Minimum
-127.61%
Maximum
768.02%
Discovering the peaks and valleys of Appili Therapeutics Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 83.44%
Maximum Annual ROE = 768.02%
Minimum Annual Increase = -783.72%
Minimum Annual ROE = -127.61%
| Year | ROE | Change |
|---|---|---|
| 2025 | 19.59% | -43.39% |
| 2024 | 34.61% | -72.30% |
| 2023 | 124.96% | -83.73% |
| 2022 | 768.02% | -783.72% |
| 2021 | -112.33% | 83.44% |
| 2020 | -61.23% | -37.51% |
| 2019 | -97.99% | 19.95% |
| 2018 | -81.69% | -35.99% |
The current ROE of Appili Therapeutics Inc. (APLIF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
59.72%
5-year avg
166.97%
10-year avg
51.81%
Appili Therapeutics Inc.’s ROE is greater than Algernon Pharmaceuticals Inc. (-98.85%), greater than ReNeuron Group plc (-72.37%), less than Ayala Pharmaceuticals, Inc. (12.17%), greater than Universal Ibogaine Inc. (-304.82%), less than Restart Life Sciences Corp. (404.52%), less than Regen BioPharma, Inc. (17.33%), greater than VG Life Sciences Inc. (0%), less than America Great Health (20.07%), less than Imagion Biosystems Limited (71.61%), less than Health Sciences Group, Inc. (2.53%),
| Company | ROE | Market cap |
|---|---|---|
| -98.85% | $1.92M | |
| -72.37% | $62.89K | |
| 12.17% | $4.41M | |
| -304.82% | $2.06M | |
| 404.52% | $2.27M | |
| 17.33% | $315.55K | |
| 0% | $2.11M | |
| 20.07% | $2.12M | |
| 71.61% | $2.21M | |
| 2.53% | $187.09K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Appili Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Appili Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Appili Therapeutics Inc.'s ROE?
How is the ROE calculated for Appili Therapeutics Inc. (APLIF)?
What is the highest ROE for Appili Therapeutics Inc. (APLIF)?
What is the 3-year average ROE for Appili Therapeutics Inc. (APLIF)?
What is the 5-year average ROE for Appili Therapeutics Inc. (APLIF)?
How does the current ROE for Appili Therapeutics Inc. (APLIF) compare to its historical average?